Drug
Naltrexone
Naltrexone: highest development phase Approved, developed by Alkermes, Teva. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Alkermes, Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| NALTREXONE | Approved | |
| Extended-Release Naltrexone NCT01180647 | Phase 3 | Opiate Dependence |
| Naltrexone NCT01449565 | Phase 2 | Amphetamine-Related Disorders |
Latest
No recent events.
Follow Naltrexone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.